PPMS patients may soon have Ocrevus as treatment

[MSUK]

Primary progressive patients may soon have Ocrevus as treatment

Results from the ORATORIO trial, exploring Ocrevus (ocrelizumab) for the treatment of primary progressive forms of multiple sclerosis) have shown the drug stopped disease progression for more than two years in more patients than a placebo...Read more - http://www.ms-uk.org/primary-progressiv ... ent-260916